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BRUSH-LIKE SURFACE USING HEPARIN/CHITOSAN BASED NANOPARTICLES FOR 
BLOOD-CONTACTING APPLICATIONS 
 
 With increasing applications of biomedical implants, it is crucial to develop surfaces that 
are blood compatible, meaning they do not induce platelet or protein adhesion. Many implants 
that are currently used to treat a wide range of problems have one major drawback, they can 
induce thrombosis. The endothelial glycocalyx plays a crucial role in preventing thrombosis. 
Based on this idea, we set out to develop a surface that has a brush-like structure similar to that 
of the endothelial glycocalyx. We developed the surface by adsorbing negatively charged 
heparin/chitosan polyelectrolyte complex nanoparticles onto a heparin/tri-methylchitosan 
polyelectrolyte multilayer. The surface was then characterized using surface plasmon resonance 
(SPR), quartz crystal microbalance (QCM), atomic force microsocopy (AFM), scanning electron 
microscope (SEM), and polarization modulation-infrared reflection absorption spectroscopy 
(PM-IRRAS). Using these techniques we confirmed that we had created a surface with brush-
like structure. Our hypothesis that the nanoparticles on the surface swell and form a brush-like 
structure when exposed to physiological conditions seems to be correct, as a result, we feel the 
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The applications of artificial implants and blood-contacting devices have grown 
significantly over the past fifty years [1]. As a result of the advances made in the biomedical 
field in regards to these devices, people have been able to live out more comfortable lives. The 
medical field makes extensive use of blood-contacting devices to treat a wide range of diseases 
from cardiovascular disease to kidney failure. For example, 200 million catheters per year, 4 
million stents per year, and 1.2 million artificial kidneys per year are used worldwide [2]. 
Devices that are in contact with blood have the potential to induce thrombosis, inflammation, and 
infection. These three processes are the greatest limitations to the long term success of the 
aforementioned devices and many others [3]. To put the failure rate into perspective, over 
550,000 vascular grafts are implanted each year in the United States and of those only 15 to 40% 
are successful; the underlying causes of failure are thrombosis, inflammation, and infection [4]. 
Conventional methods such as anti-coagulants and antibiotic therapy have proved to be 
ineffective [3, 4]. If blood-contacting materials can overcome thrombosis, inflammation, and 
infection then they have the potential to be used in numerous biomedical applications.  
To improve the long-term success of implants focus has now shifted to developing 
surfaces that are blood-compatible. It is now believed that surface properties play a huge role in 
the generation of thrombosis, inflammation, and infection [4]. In particular, it is believed that the 
endothelial glycocalyx plays a significant role in preventing thrombus formation in blood vessels 
[5, 6]. Using the endothelial glycocalyx as the model, the goal of this project is to develop and 
characterize a brush-like surface composed of heparin-chitosan nanoparticles that mimics the 
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glycocalyx with the intent of it being used as a surface coating to improve patency of 
biomaterials.  
1.2 THROMBOSIS 
To design implants and blood-contacting devices that are successful in the long term 
without the use of anticoagulants or antithrombotic drugs, effort needs to be made to understand 
how synthetic biomaterials affect mechanisms of thrombosis, inflammation, and infection. Blood 
circulation is a closed loop that carries vital nutrients throughout the body. In the event of an 
injury the body reacts by forming a clot (thrombus) which seals the damaged site and prevents 
further blood loss. Therefore, thrombus formation is an essential process that helps maintain the 
integrity of the circulatory system. The body’s response in dealing with foreign materials is very 
similar to the way it deals with injuries to the circulatory system. Thus, it is crucial to understand 
these mechanisms. Extensive research has been done in regards to the mechanisms involved in 
blood clotting but it still presents challenges, in particular the role that white blood cells play in 
coagulation [2]. Current research focuses on the role that surface-adsorbed proteins play in 
activating blood coagulation. Proteins that adsorb to the surface of biomaterials are believed to 
activate platelets, resulting in further platelet adhesion and finally leading to thrombosis and 
activation of coagulation cascade [5, 7]. 
1.2.1 MECHANISM OF THROMBOSIS 
The first step in the formation of thrombus in the event of vessel injury is the activation 
and adhesion of platelets. At the site of injury, platelets in the blood are exposed to collagen in 
the sub-endothelial matrix. Receptors on the outer membrane of platelets, glycoprotein VI and 
glycoprotein Ib, mediate the adhesion between the platelets and collagen [6, 8]. Adhesion can 
also be mediated by integrins α2β1 and αIIbβ3 which bind to collagen and fibrinogen [6, 8]. It is 
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believed that the binding of these proteins to the surface of blood-contacting surfaces is likely the 
first step in the adhesion of platelets to the surface of implants. The consequence of platelet 
adhesion further leads to thrombus formation or the inflammatory response.  
Thrombus formation is also accompanied by blood coagulation. Blood coagulation is a 
cascade that produces thrombin which converts fibrinogen into fibrin, the key component in 
stabilizing the clot. The cascade is composed of two separate pathways that ultimately lead to the 
formation of thrombin: the intrinsic pathway and the extrinsic pathway [8, 9]. The intrinsic 
pathway is activated within the first 100-200 s of initial contact between the surface and the 
blood [8]. The intrinsic pathway does not play as significant of a role as the extrinsic pathway in 
blood vessels. 
The extrinsic pathway involves the exposure of tissue factor (TF) to blood. TF is located 
in the adventitial and medial tissue layers of blood vessels [8]. The exposed TF interacts with 
factor VII to form activated factor VII. This activated factor VII then goes on to cleave factor X 
to from activated factor X. The activated factor X then interacts with factor V to form activated 
factor V. This interaction from the activated factor X and activated factor V complex has the 
ability to convert prothrombin to thrombin. Thrombin can now convert fibrinogen to fibrin, the 
key component that stabilizes a clot by forming a cross linked network. It was originally believed 
that tissue factor was located on the surface of blood vessels but evidence suggests that TF also 
circulates in the blood, secreted by monocytes and neutrophils [8]. This is a very important 
finding because it suggests that tissue factor from the blood binds to surfaces and activates the 
coagulation cascade.  
Thrombosis is an important response by the body necessary for homeostasis. But, when it 
comes to the long-term success of cardiovascular implants such as vascular grafts, stents, heart 
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valves, and vascularized tissues and organs, we need to be able to shut down thrombosis on these 
surfaces. Such a surface does exist, the endothelium has the ability to inhibit adhesion and 
activation of platelets, block the coagulation process, and mediate clot dissolution [8]. Being able 
to understand the mechanisms involved in thrombosis allows one to engineer surfaces that mimic 
the endothelium.   
1.3 ENDOTHELIAL GLYCOCLYX AND ITS COMPOSITION 
 The glycocalyx is an important constituent of the endothelium; it is believed to impart 
anti-thrombogenic properties to the vessel walls [2]. As shown in figure 1, it is located on the 
luminal side of all blood vessels and has a brush-like structure that is composed of glycoproteins, 
proteoglycans, glycosaminoglycans (GAG) and associated plasma proteins. It has an overall 
negative surface charge due to hyaluronic acid and heparan sulfate. Due to the negative surface 
charge the glycocalyx is extremely hydrophilic. Studies show that surfaces that are hydrophilic 
tend to resist non-specific protein adsorption compared to more hydrophobic surfaces [3, 5, 6, 
10, 11]. This is a result of water binding so strongly to the surface that it cannot be displaced by 
the proteins.  The thickness of the glycocalyx was believed to be on the order of nanometers but 
new evidence suggests that it can reach up to 0.5-3 µm [6, 12]. Any injury to the glycocalyx 
exposes the endothelium which rapidly leads to thrombosis [8]. This has caused researchers to 
shift their focus in studying the role that glycocalyx plays in thrombosis. 
 Aside from the surface chemistry of the glycocalyx, studies have shown that surface 
characteristics such as surface roughness also play a role in giving the glycocalyx its anti-
thrombogenic properties. Sheer rate or sheer stress is an important factor in determining which 
platelets adhere to it. At low sheer stress, proteins adhere to fibronectin, vitronectin or 
fibrinogen. At medium shear rates adhesion is mainly due to fibrinogen and at high rates vWF 
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(von-Willebrand factor) is favored [9]. Some studies have shown that at low sheer rates vWF 
circulates in the blood as a spheroid like shape whereas at very high sheer rates it is in a linear 
chain conformation. This conformation at high sheer rates makes vWF 50 times more likely to 
bind to the surface of a foreign body or injured endothelia, and as a result, platelets mainly bind 
to vWF at high sheer stress [9]. The walls of the endothelium are constantly exposed to 
mechanical forces; some studies suggest that the glycocalyx is in part responsible for the 
translation of biomechanical forces into biochemical signals [6, 13]. Thus is it important to take 
into consideration how the surface will affect the sheer rate when designing surfaces that are in 
contact with blood.  
	  
Figure 1. Electron microscopy image of the endothelial glycocalyx in a coronary capillary [12]. Current opinion in lipidology by 
LIPPINCOTT WILLIAMS & WILKINS, INC.. Reproduced with permission of LIPPINCOTT WILLIAMS & WILKINS, INC. 
in the format reuse in a dissertation/thesis via Copyright Clearance Center. 
As mentioned before surface charge is an important factor in determining the adhesion 
properties of a surface. Surfaces that are hydrophilic tend to resist protein/bacterial adhesion 
compared surfaces that are hydrophobic. Several groups have done studies to show the 
correlation between bacterial adhesion and surface hydrophilicity/hydrophobicity. For example, 
Ludwicka et al. did studies to show how different strains of S. epidermidis interact with different 
synthetic polymers. They concluded that increasing negative surface charge, which also 
increased the hydrophilicty of the surface, resulted in a decrease in bacterial adhesion [3]. Other 
groups have shown that hydrophobic surfaces adsorb more proteins, and as a result induce more 
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conformational changes in the adsorbed proteins. These conformational changes can then 
promote the inflammatory response as well as further cell adhesion and blood platelet adhesion 
[11].  
A new class of surfaces developed using polymer brushes have gained considerable 
attention do to their hydrophilic nature [5]. These surfaces have several advantages. They are 
hydrophilic, but more importantly their structure closely resembles that of the glycocalyx. This 
brush-like structure is very advantageous because not only can it resemble the glycocalyx, but 
there is also the possibility of conjugating biologically active molecules to the brush [5]. Several 
groups have successfully been able to create this brush-like surface using either grafted polymer 
chains or nanoparticles [5, 14-18].  These will be discussed in more detail later. 
Surfaces that are now being developed all have one element in common: they try to 
mimic the surface of the endothelial glycocalyx in some fashion. The most promising types of 
surfaces are those that try to imitate the anti-thrombogenic nature of the glycocalyx. The 
glycocalyx is inherently anti-thrombogenic. Injury to the glycocalyx exposes the endothelium 
which results in rapid thrombosis. Understanding the composition of the glycocalyx is the first 
step in understanding why the luminal surfaces of vessels are so anti-thrombogenic.  
 The endothelial glycocalyx is a carbohydrate-rich layer lining the luminal surface of 
blood vessels. It is linked to the surface through proteoglycans and glycoproteins. Do to the 
constant interaction with plasma this layer is in dynamic equilibrium with the components in 
blood and as a result it has variable thickness and composition [6]. The glyocalyx was first 
mentioned over 60 years ago but researchers are still having great difficulty in defining it 
geometrically. This problem arises from the fact that the glycocalyx suffers from enzymatic or 
shear-induced shedding [6, 13, 19]. The proteoglycans are considered to be the major 
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constituents of the glycocalyx, they are composed of syndecans and glypicans which are firmly 
bound to the surface and mimecan, perlecan, and biglycan which diffuse from the glycocalyx to 
the blood stream. Proteoglycans are linked to glycosaminoglycan chains of various lengths. It 
should be noted that proteoglycans are characterized by long un-branched side chains whereas 
the attached GAGs are short and branched. The glycosaminoglycan chains are what give the 
glycocalyx the brush-like structure. A simplified schematic (figure 2) shows the structure of the 
glycocalyx. Embedded in the glycocalyx is a wide range of enzymes, receptors and proteins that 
work together to regulate leukocyte and thrombocyte adhesion.  
	  
Figure 2. Simple schematic showing the glycoalyx. Syndecan and glypican are the main proteoglycans to which the 
glycosaminoglycans link to form the mesh like structure [19]. Pflügers Archiv : European journal of physiology by SPRINGER-
VERLAG. Reproduced with permission of SPRINGER-VERLAG in the format use in a thesis/dissertation via Copyright 
Clearance Center. 
 The GAG side chains are a major contributor to the overall function of the glycocalyx. 
Five types of glycosaminoglycan chains are of special interest: chondroitin sulfate, dermatan 
sulfate, keratin sulfate, heparan sulfate, heparin, and hyaluronan [6, 19, 20]. These five GAGs 
are all very similar in composition in the sense that they are all composed of linear polymer 
chains of varying length with repeating disaccharide units containing uronic acid and 
hexosamine [6, 20, 21]. The chemical structure of the various GAGs is shown in table 1. Out of 
these five, three are of great importance: heparan sulfate, chondroitin sulfate/dermatan sulfate 
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and hyaluronan. In particular, heparan sulfate because it constitutes roughly 50-90% of the total 
composition of proteoglycans making up the glycocalyx [6, 12, 20, 21]. GAGs are able to 
interact with plasma-derived proteins through numerous specific binding sites. What is also 
remarkable about GAGs is how easily they can be modified; simple chain modifications can 
have great functional consequences. The fact that GAGs can be easily modified to give 
enormous structural diversity to similar length chains, leads to a wide array of biological 
functions. The most common modifications are N-sulfonation and O-sulfation [6, 22, 23]. The 
numerous sulfation patterns and their effect on specific protein binding and modulation of 
protein function suggests that any process that alters the thickness of the endothelial glycocalyx 
could be responsible for modulating surface permeability as well as specific protein binding and 
activity.  
Table 1. The Chemical structure of glycosaminoglycans found thoughout the body [20]. Copyright © 2010 WILEY-VCH Verlag 
GmbH & Co. KGaA, Weinheim. 
















1.4 HEPARIN AND ANTI-THROMBOSIS  
Like mentioned before, the composition of the proteoglycans on the surface of 
glycocalyx is 50-90% heparan sulfate. Heparan sulfate plays an integral part in providing the 
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glycocalyx its anti-thrombogenic properties. It has been known for quite some time that heparan 
sulfate serves as a cofactor of anti-thrombin III (AT-III) which acts to inhibit thrombin.  AT-III 
is a glycoprotein that is a major serine protease inhibitor. It inhibits some of the key components 
in the coagulation cascade such as thrombin, factor Xa, IXa, and XIIa. AT-III inactivates these 
proteases by trapping them and forming a 1:1 stoichiometric complex. This results in them not 
being able to access their substrates [24]. The interaction between AT-III and thrombin is 
thought to be a result of interactions between the protease and a specific reactive peptide bond 
within AT-III [25]. Thrombin in an attempt to attack the reactive peptide bond within AT-III, 
activates AT-III and becomes trapped. This leads to an inactive anti-thrombin-protease complex. 
The formation of anti-thrombin-thrombin complex has been shown to occur at a relatively slow 
rate but the presence of heparin has been shown to accelerate this interaction significantly [25]. 
Several studies have shown the significant effect that heparin has on anti-thrombin by studying 
the change in rate constants in the presence of heparin and without heparin. Without heparin, the 
rate constants for thrombin, factor XA and factor IXa inactivation are 7-11 x 103, 2.5 x 103 and 1 
x 10 M-1s-1 respectively whereas in the presence of heparin the rate constant jumps to 1.5 -4 x  
107 M1s-1 [24, 26-30]. As can be seen, the presence of heparin has a significant effect on the 
inactivation of the aforementioned thrombin inducing factors. To put it into perspective, the 
reaction for anti-thrombin-thrombin reaction is increased by 2000-4000 fold.  
Anti-thrombin activity is significantly increased when it interacts with two specific 
domains on heparin. The first domain consists of eight or more oligosaccharide sequences, this 
domain binds to a discrete region in anti-thrombin to increase factor Xa-AT-III interactions [25]. 
The second domain which is responsible for thrombin inactivation contains polysaccharides that 
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are 16 or more residues [25].  Do to the effect of heparin on AT-III future technologies are 
focused on developing surfaces that incorporate heparin in some fashion. 
 Like mentioned earlier, the mechanisms for thrombus formation are clearly understood 
but what is still somewhat unclear is how foreign surfaces alter the coagulation pathway. Many 
groups have come to the consensus that the endothelial glycocalyx is a key component in 
regulating the blood-clotting cascade in particular the heparan sulfate. For this reason many 
surface modifications incorporate heparin on their surfaces. Heparin has been used as an anti-
coagulant for quite some time now, but it has limitations. Once the implant is inserted in the 
patient heparin must be administered on a regular basis. The down side of using heparin in 
anticoagulation therapy is the potential of forming heparin-induced thrombocytopenia. This 
results when heparin, which has a negative charge, forms a complex with positively charged 
platelet factor 4 (PE4). This complex then becomes the target of the immune system with the 
final outcome being venous and arterial thrombosis [31, 32]. Adverse reactions like these have 
caused researchers to look for alternative techniques to deal with surface-induced thrombosis. 
1.5 BLOOD COMPATIBLE SURFACES 
 The problem of developing a truly blood compatible surface is being investigated by 
countless groups around the world. Great progress has been made in this field but a lot more 
work needs to be done before there are truly blood-compatible surfaces. This all stems from not 
fully understanding how biomaterials interfere with the coagulation cascade. Groups have taken 
advantage of how heparan sulfate on the surface of endothelial cells interacts with anti-thrombin 
to develop heparin coated surfaces that show great potential [28, 30, 33]. Other groups have tried 
to make surfaces that mimic the structure of the glycocalyx with the hypothesis that surface 
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topography is equally as important as is the chemistry [10, 14]. Studies relating to surface 
typography will be closely examined. 
1.5.1 HEPARIN-BASED SURFACES 
 To improve the compatibility of surfaces a common technique is to coat the surface with 
heparin. Many studies have been done to show that surfaces coated with heparin are more likely 
to resist platelet adhesion. Many of the biomedical devices that are in use today are made using 
titanium; titanium is a very good starting material for biomedical devices because of its 
properties such as low modulus and corrosion resistance. But the down side of titanium is that it 
is very thrombogenic compared to other biomaterials. Chen et al. have shown that coating 
titanium with heparin multilayers improves their blood compatibility [33]. They coated titanium 
surfaces using a layer by layer (LbL) technique. This technique involves coating the surface with 
oppositely charged polyelectrolytes that are then alternatively adsorbed on to the surface. LbL is 
very flexible in that it allows one to control the layer thickness down to the nanometer scale, and 
it is not limited by shape of surfaces. Chen et al. used heparin-collagen multilayers on titanium to 
improve the blood compatibility of titanium cardiovascular implants. They exposed titanium 
surfaces to platelets and compared them to surfaces coated with heparin-collagen multilayers. 
Using SEM they observed that both surfaces adsorbed platelets but the heparin-collagen 
adsorbed about half the amount as the titanium surfaces. They also observed that the platelets on 
the heparin-collagen surfaces were not activated platelets. Two additional anticoagulant assays 
were performed, the activated partial thromboplastin time (APTT) and the prothrombin time 
(PT) tests. These two tests measure the time activity of the intrinsic and common pathway of 
blood coagulation. The study showed that the APTT and PT for untreated titanium were 49.2 + 
3.8 s and 18.8 + 0.8 s respectively whereas surfaces coated with heparin-collagen the APTT and 
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PT were 132.8 + 14.9 s and 35.3 + 6.0 s respectively [33]. This study showed that coating 
surfaces with heparin is an effective technique of improving the blood compatibility of surfaces. 
1.5.2 GLYCOCALYX-MIMETIC SURFACES  
 The multilayer technique shows great promise in treating biomaterial-induced thrombosis 
but researchers have taken it a step further by trying to design polymer-based brush-like surfaces 
that they believe will mimic the glycocalyx. Multiple groups have approached this problem and 
have come up with several techniques to design these surfaces. Some groups have tried to design 
these surfaces by grafting polymer chains on to surfaces with varying densities whereas other 
groups have used nanoparticles to achieve similar brush-like surfaces [10, 14]. Both types will be 
discussed in detail. 
 Grafting polymer chains on to surfaces to mimic the glycocalyx has gained considerable 
attention in regards to preventing biomaterial-induced thrombosis. Several different polymers 
have been used in this application ranging from natural polysaccharides to poly(ethylene glycol) 
(PEG). Gupta et al. set out to create a glycocalyx-mimetic surface using dextran modified 
poly(vinyl amine) [10]. The advantage of poly(vinyl amine) (PVA) is that it adsorbs to a wide 
range of biomaterial surfaces spontaneously [10]. The chemical structures of both PEG and PVA 
is shown in figure 3. They successfully designed the surface and performed various tests to see 
whether the surface was able to resist platelet adhesion, as well as testing for the stability of the 
surface. The schematic of the surface they were trying to achieve is shown in figure 4.  An 
important property of the surface is how stable it is, if the surfaces starts to shed under sheering 
then there is the potential that the exposed surface will allow platelet adhesion. They checked the 
stability of the surface by fluorescently labeling the surface and then exposing it to flowing 
blood. They observed that there was no change in the intensity before and after exposure to 
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whole blood indicating that the brush-like structure was stable. They also performed platelet 
adhesion studies under various sheer stress conditions ranging from 0 dyne/cm2 to 80 dyne/cm2. 
Their studies showed that uncoated surfaces had roughly 35,000 adhered platelet number/mm2 at 
no sheer and this value drops below 10000 adhered platelet number/mm2 at sheer stress above 60 
dyne/cm2. For surfaces coated with poly(vinyl amine) they observed that the adhered platelets 
number/cm2 never goes above 5000 and stays relatively constant regardless of an increase in 
sheer stress [10].  
Currently PEG is used as the benchmark for reducing protein adsorption and platelet 
adhesion on blood-contacting materials but the chain length, surface density, and surface 
heterogeneity play a crucial role in determining the surface properties of PEG which affect the 
repulsion barrier. Gupta et al. believe that PVA will overcome these, because unlike PEG 
oligosaccharides have no amphiphilic or surface-active characteristics [10]. They believe that 
PVA is superior to PEG; the only difficult part about PVA is getting a dense uniform coverage 
on the surface. Do to the inherent properties of PEG a low surface density still allows it the 
ability to be able to spread over the surface. PVA on the other hand cannot get away with a less 
dense packing because this exposes the surface underneath, allowing platelet adhesion. 
According to Gupta et al. there is a huge variability between surfaces coated with dextran that is 
oriented “end on” and “side on”. The variability can be reduced to nothing if the packing density 
can be increased significantly. The advantage that PVA has over PEG is that it will not undergo 
interfacial dehydration under dense packing. They are successful in their attempt to make a 
densely packed surface by modifying the dextran so that it has more sites for binding the surface. 
This enables them to create a surface with a dense packed surface of dextran modified poly(vinyl 
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amine) that resembles the brush-like structure of the glycocalyx. This surface was shown to 






Figure 3. The chemical structure of PVA (left) and PEG (right). Biomaterials by Biological Engineering Society Reproduced 
with permission of PERGAMON in the format reuse in a thesis/dissertation via Copyright Clearance Center. 
 
	  
Figure 4. Schematic of glycocalyx-mimetic surface using dextran-modified poly(vinyl amine) [10]. Biomaterials by Biological 
Engineering Society Reproduced with permission of PERGAMON in the format reuse in a thesis/dissertation via Copyright 
Clearance Center. 
Several groups have created these brush-like surfaces using various polymers. They all 
have one goal in mind and that is to create a high density brush-like surface that mimics the 
glycocalyx in terms of anti-thrombogenicity [15-17]. The starting material for a lot of these 
surfaces is simple carbohydrates. Yu et al. designed glycopolymer brushes using mannose, 
galactose and glucose residues in the pyranose form [5]. The reason for using carbohydrates is 
because they are abundantly present on the surface of the endothelial glycocalyx. This group was 
also able to show that their surface was able to resist platelet adhesion. Another important 
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finding of their study was that brush surfaces based on glucose adsorbed lower amount of protein 
than the mannose or galactose brushes [5]. These studies also confirmed that brush density is a 
critical factor in protein adsorption. Many groups have been able to graft polymer chains on the 
surface of various biomaterials but the challenge lies in getting a very dense coating.    
 While some groups have managed to graft polymer chains onto surfaces to mimic the 
glycocalyx others have approached the problem from another perspective. Instead of grafting 
polymer chains onto surfaces some groups have resorted to binding nanoparticles onto surfaces. 
The end goal is the same for both techniques, to obtain a brush-like surface that has the potential 
to mimic the glycocalyx. Barrientos et al. set out to create a surface using gold 
glyconanoparticles that has the potential to be used for a wide range of applications in the 
biomedical field [14]. They developed their nanoparticles by using a gold sphere core with 
neoglycoconjugates of naturally occurring oligosaccharides bound to the entire outer surface 
thus, giving a globular shape. When they form clusters on the surface they resemble the brush-
like structure that is so sought after. Figure 5 shows a simple schematic of how this group 
attempted to create this brush-like surface. One of the main objectives of this group was to 
develop a surface that was resistant to cell-adhesion processes, to achieve this objective they 
wanted to make sure that their surface was stable in regards to enzymatic degradation. They 
believed that the steric crowding of the carbohydrate groups on the surface would allow it to go 
undetected by degradation enzymes [14]. This is exactly what they observed experimentally; 
highly dense nanoparticles were able to resist hydrolysis by β-galactosidase whereas less dense 




Figure 5. Scheme for making brush-like surfaces using gold glyconanoparticles [14]. Chemistry : a European journal by 
Gesellschaft Deutscher Chemiker ; et al Reproduced with permission of WILEY - V C H VERLAG GMBH & CO. KGAA in the 
format reuse in a dissertation/thesis via Copyright ClearanceCenter.	  
1.6 GLYCOCALYX-MIMETIC SURFACES USING POLYELECTROLYTE COMPLEX 
NANOPARTICLES 
 While surfaces made using polymer brushes and surfaces made using nanoparticles show 
great promise there has not been a lot of work done in regards to obtaining brush-like surfaces 
using nanoparticles. Much of the work reviewed above is focused on using polymers such as 
PVA and PEG to create brushes. Like mentioned before, the major problem when grafting 
polymer chains on to surfaces is obtaining a uniform and dense coverage. Without a dense 
coverage the underlying surface is exposed to blood and therefore is much more prone to platelet 
adhesion. It has been already shown by several groups that we can engineer surfaces that have 
somewhat a brush-like structure using polymer chains but very few groups have explored the 
idea of obtaining brush-like surfaces using clustered nanoparticles.  
 The idea behind using clustered nanoparticles as opposed to grafting polymer chains is 
very appealing because it is easier to get a uniform coverage of the surface using nanoparticles 
than using grafted polymer chains. In particular, nanoparticles synthesized using polyelectrolyte 
polysaccharides are of great significance. These nanoparticles have a significant advantage in 
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that they are made using the same GAGs found on the endothelial glycocalyx, heparin. Previous 
work done in our lab has been able to develop surfaces using nanoparticles but their potential as 
protein resisting surfaces was never explored [34].  
 It has been known for quite some time now that when two polyelectrolytes are mixed in 
solution they form colloidally stable polyelectrolyte complex nanoparticles (PCNs). Work done 
by Boddohi et al. has shown that mixing two different polyelectrolyte polysaccharides will result 
in the formation of PCNs [35]. In his work he was able to create various combinations of PCNs. 
The formation of stable PCNs is obtained when two oppositely charged polyelectrolytes are 
mixed in non-stoichometric amounts. The PCNs carry a charge depending on which 
polyelectrolyte was used in excess. This allows for the creation of PCNs with either an overall 
positive or negative charge depending on the application. For applications for anti-thrombogenic 
surfaces we are going to use PCNs that are made using heparin and chitosan which will have an 
overall negative charge. When these PCNs are exposed to PEMs made using polyelectrolyte 
polysaccharides they attach through charged interactions. For example, if the PCNs are of 
negative charge then they will bind to multilayers that are positively terminated and vice versa. 
The final shape of the PCNs can vary depending on how big of a difference there is in the 
molecular weights of the polyelectrolytes used. The two different conformations can be seen in 
figure 6.  Unlike other nanoparticles, PCNs made using polyelectrolyte polysaccharides have an 
additional advantage in that they are water soluble making them perfect for use in biomedical 




Figure 6. Formation of PCN using polyelectrolytes with signicantly diferent molecular weight [20]. Copyright © 2010 WILEY-
VCH Verlag GmbH & Co. KGaA, Weinheim. 
 Previous work has shown that these nanoparticales are able to bind to the surface but no 
work has been done regarding its ability to resist platelet and protein adhesion [34]. As 
previously mentioned, the goal of this project is to take the surface that has been previously 
developed and see whether or not it has the potential to be anti-thrombogenic. Gold substrates 
will be used on which multilayers of heparin and trimethyl-chitosan (Tmc) will be formed. The 
PEMs give a solid foundation on which the negatively charged heparin/chitosan particles can 
bind. They hypothesis is that once the surface is exposed to physiological conditions the PCNs 
will swell and form a brush-like surface. Since the PCNs are made up of numerous polymers we 
can expect them to swell greatly and in turn cover the entire underlying surface.  The PCNs in 
the swollen state will mask the underlying surface and therefore prevent protein adhesion, in 
particular fibrinogen adhesion.  
 The nature of the PCN-coated surface will be studied using surface plasmon resonance 
(SPR), quartz crystal microbalance (QCM), atomic force microsocopy (AFM), scanning electron 
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microscope (SEM), and Polarization modulation-infrared reflection adsorption spectroscopy 
(PM-IRRAS). Each technique offers a unique perceptive on the properties of the surface. By 
using SPR we can monitor the adsorption of the multilayers and PCNs. AFM and SEM can then 
be used to see how well the PCNs cover the surface; dense surface coverage of PCNs as opposed 
to very bare surface with few PCNs here and there. Data collected from QCM will allow us to 
study the thickness and viscoelastic properties of the swollen PCNs. Lastly, PM-IRRAS can be 
used to analyze the surface chemistry. By themselves each technique only tells limited 
information about the surface but if used in conjunction with one another we can determine if we 
have a surface that will be suitable for blood-contacting applications; the nanoparticles swell 
under liquid and form a brush-like structure that covers the underlying surface.  
 Fibrinogen adsorption will be performed on various surfaces and then compared to see if 
the surface coated with PCNs is superior to other techniques. The surfaces that we will compare 
our PCN surface to is a surface with Hep/Tmc multilayers with either Hep or Tmc terminating 
layers and a surface with Hep/Chi multilayers with either Hep or Chi terminating layers. The 
PCN coated surfaces will be prepared with Hep/Chi and Hep/Tmc underlying multilayers with 
nanoparticles adsorbed on top. The expectation is that our nanoparticles coated surface will resist 
fibrinogen adsorption better than the other surfaces, telling us that not only is the surface 











Chitosan (Chi) was obtained from novamatrix  (Protosan UP B 90/20, 5% acetylated, Mw 
= 80 kDa, PDI = 1.52, Sandvika, Norway). Heparin sodium (Hep) was obtained from Celsus 
Laboratories (from porcine intestinal mucosa, 12.5% sulfur, Mw = 14.4 kDa, PDI = 1.14, 
Cincinnati, OH). N,N,N-Trimethyl chitosan (Tmc) was synthesized in our own lab using the 
procedure described by de Britto and Assis [36]. The degree of quaternization of the Tmc was 
determined to be 18%. 11-Mercapto-undecanoic acid (MUA) 95% and fibrinogen was purchased 
from Sigma-Aldrich (St. Louis, MO). Both glacial acetic acid and ethanol (200 proof 99.5 + %) 
were purchased from Acros Organics (Geel, Belgium). Sodium acetate anhydrous, sodium 
chloride, potassium chloride, and sodium phospahate dibasic anhydrous were all purchased from 
Mallinckrodt Chemicals (St. Louis, MO). Sodium phosphate monobasic monohydrate was 
purchased from fisher scientific (Pittsburgh, PA). SF-10 glass chips were purchased from GWC 
Technologies (Madison, WI). A Millipore synthesis water purification unit (Millipore, Billericia, 
MA) was used to obtain 18.2 MΩ cm water that was used to make all aqueous solutions.   
 
2.2 CONSTRUCTION OF HEPARIN/CHITOSAN POLYELECTROLYTE COMPLEX 
NANOPARTICLES. 
Hep/Chi polyelectrolyte complex nanoparticles (PCN) were prepared my first making 
0.95 mg/ml and 0.9 mg/ml pure polymer solutions of heparin and chitosan in acetate buffer 
solution (0.1 M pH 5) respectively. The solutions were allowed to stir for an hour and then 
filtered using 0.2 µm  syringe filters (PVDF, Fisher Scientific). Negatively charged PCNs were 
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prepared by using heparin as the starting solution and then adding chitosan. One part by volume 
chitosan was mixed into six part by volume heparin using one shot addition. The advantage of 
one shot addition is that it minimizes flocculation of PCNs when the charge mixing ratio is close 
to 1 [36]. The mixture was then allowed to stir for three hours, at which point it was turned off 
and left over night to settle and thus remove aggregated particles. The following day the PCN 
mixture was separated into small 1.5 mL Eppendorf centrifuge tubes. The solutions were then 
centrifuged at 9000 rcf for 15 min using an Eppendorf 5804 centrifuge (Eppendorf, Westbury, 
NY). After being centrifuged the supernatant was removed leaving behind the PCNs. The PCNs 
in each centrifuge tube were then re-suspended 150 µL Millipore water. The PCN pellet might 
take a while to break down but once it does all the mixtures were combined and stored in the 
refrigerator. Calculating the yield of the nanoparticles is described in our previous work; it was 
determined to be 60% [35]. The concentration after re-suspension was calculated to be 8 mg/ml. 
Dynamic light scattering and zeta potential measurements were also performed according to our 
previous work [35]. Based on these measurements it was found that the Hep/Chi nanoparticles 
have an effective diameter of 410.5 + 2.2 nm, and a zeta potential of -51.79 + 0.93 mV.  
 
2.3 PREPARING THE HEP, TMC, CHI, AND FIBRINOGEN SOLUTIONS FOR 
CONSTRUCTION OF PEM 
The PEMs were constructed using Tmc and Chi as the polycation and Hep as the 
polyanion. These solutions are needed to create Hep/Chi and Hep/Tmc PEMs. The chemical 
structure of Tmc and Chi is shown in figure 7 to emphasize the difference between Chi and Tmc. 
The three solutions of 0.01 M Tmc in acetate buffer (0.2 M pH 5), 0.01 M Chi in acetate buffer 
(0.2 M pH 5), and 0.01 M Hep in acetate buffer (0.2 M pH 5) were prepared. The solutions were 
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stirred for an hour and then filtered using a 0.22 µm syringe filter. They were then stored in the 
refrigerator until needed.  A rinse solution was prepared by acidifying water to pH 4.0 using 
acetic acid. A 0.12 mg/ml solution (PBS pH 7.3 0.15M) of fibrinogen was also prepared. 
	  
Figure 7. The chemical structure of N,N,N-Trimethyl chitosan and chitosan that shows the difference between the two. As can be 
seen  above the amine in chitosan becomes methylated to turn it into N,N,N-Trimethyl chitosan. Reprinted (adapted) with 
permission from Almodovar J, Place LW, Gogolski J, Erickson K, Kipper MJ. Layer-by-Layer Assembly of Polysaccharide-
Based Polyelectrolyte Multilayers: A Spectroscopic Study of Hydrophilicity, Composition, and Ion Pairing. Biomacromolecules. 
2011;12:2755-65. Copyright © 2011, American Chemical society.  
2.4 PEM ASSEMBLY AND IN SITU FOURIER-TRANSFORM SURFACE PLASMON 
RESONANCE 
Polyelectrolyte multilayers based on Hep and Tmc and Chi were constructed on SF-10 
glass. Before constructing the PEM on the SF-10 glass it had to be prepared by allowing a self-
assembled monolayer (SAM) of MUA to adsorb on to the surface. The SF-10 glass was exposed 
to a solution of 0.001 M solution of MUA dissolved in 200 proof ethanol and left overnight. The 
MUA is rich in carboxylic acid groups which form a perfect foundation for positively charged 
polyelectrolytes such as Tmc and Chi to bind [34]. The surface is now ready to be used in FT-
SPR experiments. Fourier-transform surface plasmon resonance (FT-SPR) is a very useful 
instrument when it comes to studying adsorption of thin films onto surfaces. The fundamental 
concept behind the FT-SPR is that it measures the reflectivity of p-polarized light beam as a 
function of incident light wavelength. At a specific incident light wavelength, surface plasmons 
at the metal/dielectric interface are created. These surface plasmons absorb some of the incoming 
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light which can be observed as a minimum in reflectivity. The position at which this minimum 
occurs at is called the SPR angle. The SPR angle is sensitive to the thickness and index of 
refraction of any adsorbed material on the metal surface [37]. By using this technique, we can 
detect changes in refractive index as well as thickness of the PEM on the gold surface. 
The assembly of PEM was performed in a flow cell of an SPR-100 module connected to 
a Nicolet 8700 FT-IR spectrometer (Thermo-Electron, Madison, WI). A Masterflex peristaltic 
pump (Cole-Parmer, Vernon Hills, IL) set to medium speed was used to pump the rinse and 
polyelectrolyte solutions through the flow cell. The appropriate angle of incidence was 
determined by observing at what angle the minimum in reflectivity is at 9000 cm−1 wavenumber. 
The configuration of the FT-SPR was as follows, a white light/near infrared source was used 
along with a CaF2 beam splitter at the interferometer and an InGaS detector. All of the data was 
collected using Omnic 8 software (Thermo Electron). The data was collected at a resolution of 8 
cm−1 over a range of 6000 to 12000 cm−1. Sixteen scans were performed at each time point and 
coadded to give an FT-SPR spectrum every 4.7 s. 
The underlying PEM surface was prepared by using either Chi as the polycation or Tmc 
as the polycation and Hep as the polyanion. The procedure for creating Hep/Chi PEMs is same 
as that for creating Hep/Tmc PEMs so only one will be described. The Hep/Tmc PEMs were 
prepared by exposing the substrate to alternating solutions of Tmc and Hep for 5 min. In between 
each step the substrate was rinsed using the rinse solution. All the PEMs constructed contained a 
total of 7 layers with Tmc being the initial and final layer of the PEM. Three different substrates 
were prepared, a substrate that was Hep terminated and then exposed to fibrinogen, a substrate 
that was Tmc terminated and then exposed to fibrinogen, and a substrate that was Hep/Chi PCN 
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terminated and exposed to fibrinogen. The shift in position of the FT-SPR peak center of gravity 
can be used to determine the layer thickness [38]. 
2.5 SCANNING ELECTRON MICROSOPY 
 The surface of the substrates coated with Hep/Chi nanoparticles was imaged using JEOL 
JSM-6500F field emission scanning electron microscope (SEM) (Heol, Peabody, MA). The 
surfaces created in the FT-SPR are imaged using SEM to further analyze the distribution of 
nanoparticles on the surfaces of the Hep/Chi and Hep/Tmc based PEMs. Before imaging, the 
surface was coated with 10 nm gold using an argon atmosphere evaporator. Images were taken at 
700x magnification using accelerating voltage of 5.0 kV. 
2.6 ATOMIC FORCE MICROSOPY 
Atomic force microscopy (AFM) images of the nanoparticle terminated surface were 
taken using a dimension 3100 AFM microscope (Digital Instruments, Santa Barbra, CA) and 
Nanoscope III 4.43r8 software. The AFM was also used with the intention of studying the 
distribution of nanoparticles on the surfaces of Hep/Chi and Hep/Tmc based PEMs. Tap300-G 
Silicon AFM probes with resonant frequency of 300 kHz and force constant of 40 N/m were 
purchased from Ted Pella, Inc and were used for all the AFM imaging.  
2.7 MULTILAYER ASSEMBLY USING QUARTZ CRYSATAL MICROBALANCE 
 Surfaces containing the PEMs and PCNs were constructed on AT-cut piezoelectric gold-
coated sensor crystals (Q-Sense, Inc., Glen Burnie, MD). Before the PEMs were constructed, the 
substrates were soaked in 1 mM solution of MUA in ethanol for 24 hours. MUA is a good base 
upon which the PEMs are formed. Chi and Tmc were used as the polycation and Hep was used 
as the polyanion for the Hep/Chi and Hep/Tmc based PEMS. Their preparation is described in 
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section 2.3. The assembly of the PEMs was performed on the QCM-D crystals in a Q-sense E4 
quartz crystal microbalance (QCM) with dissipation monitoring system (Q-sense, Inc.). The 
software used to record and analyze the data was QSoft 401 and QTools 301 (version 3.0.17.560) 
respectively. The flow rate used to construct the PEMs was set to 200 µl/min. The surface was 
constructed with a total of 7 layers with Tmc being the initial layer and then alternating between 
Hep and Tmc and finally terminating with a Tmc layer. The formation of the Hep/Chi PEM is 
exactly the same except Chi is used instead of Tmc. In between each step a rise step is 
performed. The time that the surface was exposed to each polyelectrolyte varied throughout the 
experiment. The reason being, it took quite some time for the frequency to stabilize during each 
step. 
2.7.1 KELVIN-VOIGT VISCOELASTIC MODELING FOR PCN-COATED SURFACE 
 QCM is a very powerful technique that allows one to characterize surface properties of 
thin films. Therefore, it was the logical choice in characterizing the coating of PEM and PCN 
process. The fundamental idea behind the QCM is that a change in the resonance frequency of 
the quartz crystal is correlated with the mass of the film. In particular, for films that are rigid a 
decrease in resonance frequency of the quartz crystal is linearly correlated with mass of the film 
according to the Sauerbrey model (Equation 1) [34, 39-41].  




Where, Γ!"#!! is the mass adsorbed per unit area, 𝐶 (17.7 ng cm−1) is the mass sensitivity 
constant, 𝑛 is the overtone, and Δ𝑓! is the frequency shift for overtone 𝑛. A major assumption 
made in the Sauerbrey model is that the adsorbed mass is evenly distributed, sufficiently rigid 
and has no energy dissipation.  In cases where the films are viscoelastic and not rigid then this 
model becomes invalid because dissipation has to be taken into account in order to get an 
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accurate description of the films. Because we are assuming that the nanoparticles are swollen 
they have viscoelastic behavior and as a result we need to consider dissipation to accurately 
model the structural properties of the PCNs. The definition of dissipation is described as the 
energy loss of an oscillatory system during one period of oscillation [39]. In mathematical terms 




 Equation 2.5.2 
where 𝐸!"##"$%&'! is the dissipated energy, 𝐸!"#$%& is stored energy in the oscillating system and 
𝐷 is the sum of all energy dissipated in the oscillatory system. 
 A more accurate model that describes viscoelastic materials is the Kelvin-Voigt model. 
The model is based on a dash pot-spring configuration to describe the viscoelastic properties of 
materials. The model is described as: 
 𝐺∗ = 𝐺! + 𝑖𝐺!! = 𝜇! + 𝑖2𝜋𝑓𝜂! Equation 2.5.3 
where 𝐺* is complex shear modulus, 𝐺! is the storage modulus, and 𝐺!! is the loss modulus. The 
Q-tool software has the ability to take the measured Δ𝑓 and 𝛥𝐷 data and interpret it based on the 
Kelvin-Voigt model to estimate the viscoelastic properties of the adsorbed nanoparticles. The 
underlying assumptions made by this model are that the film must be laterally homogenous and 
evenly distributed, the bulk fluid is Newtonian, the adsorbed layer couples perfectly to the sensor 
(no slip), and the film is soft/viscoelastic [41].  If these conditions are met then viscoelastic 
properties such as density, viscosity, elasticity, and thickness of the adsorbed nanoparticles can 
be correlated to the Δ𝑓 and ΔD from the QCM-D response [39]. Voinova et al. developed a 
mathematical relationship between the QCM-D response and the viscoelastic properties of the 




























 Equation 2.5.5 
where  𝜌! and ℎ! are the density and thickness of the quartz crystal. 𝜂! is the viscosity of the 
bulk fluid and 𝛿! defined as 𝛿! =    2𝜂!/𝜌!𝜔 is the viscous penetration depth of the shear wave 
in the bulk fluid and 𝜌! is the density of the bulk fluid.  𝜔 is the angular frequency of the 
oscillator. Since the QCM-D instruments can measure multiple overtones of the fundamental 
frequency (n=3,5,7,9,13), it can use the built-in algorithm to solve for the parameters that 
describe the nanoparticles: density (𝜌!), viscosity (𝜂!), shear elasticity (𝜇!), and thickness (𝛿!). 
In our case, since the nanoparticles are coated to a surface that already has PEMs we had to 
model the surface with two separate layers. Q-tools has the ability to model two separate layers 
with the bulk fluid being automatically the third layer. We assumed that the underlying PEM 
layer was a single layer, even though it is composed of seven individual layers, and the PCN was 
its own layer. Using the Q-tools we were able to model the surface in several different 
configurations (figure 8). Since there are two layers we have to provide the software with bulk 
fluid density and viscosity (997.62 kg/m3 and 0.000933 kg/ms at 23 °C respectively). We also 
have to provide the density of the PEM layer and the PCN layer. We assumed that the density of 






Figure 8. The various configurations that were modeled using Q-tools software. The PEM layer is composed of 7 layers of 
alternating Hep/Tmc monolyaers, starting with  Tmc and terminating with Tmc. The nanoparticles have an overall negative 
charge and are made using heparin in excess and chitosan as the limiting reagent. The protein used in these studies was 
fibrinogen.  
2.8 POLARIZATION MODULATION-INFRARED REFLECTION ADSORPTION 
SPECTROSOPY (PM-IRRAS) 
 Polarization modulation-infrared reflection adsorption spectroscopy (PM-IRRAS) on the 
surface containing the multilayers and the PCN was performed to investigate the surface 
chemistry. A Nicolet 8700 FT-IR Spectrometer (Thermo-Electron) configured with a Tabletop 
Optics module equipped with a PEM-90 photoelastic modulator (Hinds Instruments, Hillsboro, 
OR) to provide the polarization of the incident infrared light, a liquid nitrogen cooled MCT-A 
detector, and a demodulator (GWC Technologies) to process the s- and p-polarized reflection 
spectra [34, 36]. 1000 PM-IRRAS spectra were collected for the different surfaces at 8 cm−1 
resolution. The PM-IRRAS was corrected using a cubic spline approximation for the background 
signal in IgorPro (version 5.0.5.7, Wave Metrics, Portland, OR). This was done to remove the 
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second-order Bessel function by dividing by a baseline. The spline-points for the baseline were 

























RESULTS AND DISCUSSION 
3.1 BACKGROUND 
 Developing a surface that mimics the structure of the glycocalyx would be a huge 
breakthrough in the field of blood compatible devices. Since the glycocalyx is believed to play 
an essential role in preventing thrombosis, we look to it for answers. We believe that the brush-
like structure is one of the key reasons for the glycoalyx having anti-thrombogenic properties. 
We developed a surface that we believe will have a brush-like structure, similar to the 
glycocalyx, using heparin (Hep)/chitosan (Chi) based nanoparticles coated onto surfaces with 
Hep/Trimethyl chitosan (Tmc) polyelectrolyte multilayers (PEMS). The surface morphology of 
the dry surface is characterized using the scanning electron microscope and atomic force 
microscope. We believe that under dry conditions the polyelectrolyte complex nanoparticles 
(PCN) are in a collapsed state but once the surface is immersed in liquids these PCNs swell and 
form a brush-like coating similar to the glyocalyx. The surface properties under liquid were 
characterized using surface plasmon resonance (SPR) and quartz crystal microbalance (QCM). 
The results obtained from both SPR and QCM were used in conjunction to see whether or not 
our original hypothesis that the nanoparticles swell up and form a brush-like surface similar to 
the glycocalyx was correct.  
3.2 FORMATION OF PEMS AND PCN-COATED SURFACE USING SPR 
 The plot showing the formation of the Hep/Tmc PEMs containing negatively charged 
Hep/Chi PCNs was monitored using SPR. The SPR data for the formation of Hep/Chi PEMs is 
not presented because it was later observed that Hep/Chi PEMS do not adsorb nanoparticles as 
well as Hep/Tmc PEMs, this will be discussed in further detail in section 3.3. The formation of 
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the surface is shown in the FT-SPR time series in figure 9. For the first five minutes the surface 
was exposed to acidified rinse. After the initial acidified rinse the surface is exposed to Tmc 
solution at which point we see a shift in the peak position indicating a change in refractive index 
from the acidified rinse to the Tmc solution. Once the solution is switched back to the acidified 
rinse we see that the peak shift back up because now the refractive index changes from the Tmc 
solution to that of the acidified rinse. The peak position not going back to its original position is 
an indication that there is adsorption of multilayers. The adsorption process for the Hep-
terminated and Tmc-terminated is shown in figure 10, from this we can see the adsorption of the 
PEMs as well as some adsorption of fibrinogen. The model calculates the thickness of each layer 
by using multiphase Fresnel calculations to predict the FT-SPR peak for an array of thicknesses. 
This requires knowing thickness of the gold layer (45 nm) as well as the refractive index of SF-
10 glass, gold, PEM, and rinse solutions. The refractive index of the PEM solutions was 
calculated using ellipsometry in our previous work [36]. The algorithm was based on a script 
created by Prof. Robert Corn from the University of California, Irvine. A detailed analysis of this 
procedure can be found in the sporting information of previous work done in our lab [36]. By 
fixing the angle of incidence to 51.2° as well as the refractive index of all the solutions, the only 
adjustable parameter is the thickness of the PEM.      
The FT-SPR curves were predicted using the algorithm with the thickness being the 
independent variable. Using this technique we were able to determine the thickness for each 
surface we created, heparin terminated and Tmc terminated in figure 10 while PCN terminated 
on table 2. As can be seen on this table the thickness of the seven underlying PEMs is 
approximately 6.20 + 0.15 nm. These results agree with previous work done in our lab, in which 
we also found that the height of seven layers composed of Tmc and Hep is approximately 6 nm. 
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The thickness of the eighth layer is not what we expected, because we assumed that the 
refractive index of the PCN layer is the same as that of the Hep/Tmc layers. Another explanation 
for the PCN layer having such a small thickness could be attributed to the SPR not being able to 
measure this layer properly. We assumed that when the surface is exposed to liquid, the 
nanoparticles swell and form a brush-like structure. As a result of swelling the nanoparticles 
absorb a lot of water. As mentioned in chapter 2, the SPR is sensitive to refractive index contrast. 
If the nanoparticles are severely hydrated then they will have a similar refractive index to that of 
water. As a result, there is no contrast and the PCN layer cannot me accurately measured. It 
should be noted that the data presented in table 2 is calculated using the model based on the 
assumption that the nanoparticle layer has the same refractive index as that of the PEM layer. 
This assumption is not accurate if the nanoparticles are hydrated which they might be in our 
case. Even though the SPR cannot measure the thickness, it still can tell us whether or not the 
nanoparticles adsorbed on to the surface. In our case they did, and this was later confirmed using 
SEM and AFM imaging. 
 The model that we used to predict the FT-SPR curves is based on the theory developed 
by Wilford Hansen [42]. The model he developed for predicting the FT-SPR curves is based on 
the assumption that there are three phases. In our case the three phases are the gold film, the 
PEM film, and the prism. We could add a fourth phase for the PCN layer to account for the fact 
that it has a different refractive index than the PEM layer, but this requires us to make the 
assumption that the interfaces between layers are smooth and discrete which may not be the case. 
We relied on the SPR to confirm that the nanoparticles had deposited on to the surface and then 
confirmed using SEM and AFM imaging. Instead of using SPR we used QCM in the hopes that 
it will be better able to characterize the PCN-coated surface. 
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Table 2. Thickness of the PEM surface, layers 1-7 are composed of Heparin and Tmc. The first and seventh layers are Tmc 
layers. The eight layer is the Hep/Chi PCN layer assuming that it has the same refractive index as the polyelectrolyte solutions. 
Layer Thickness (nm) 
1 0.70 + 0.04 
2 1.03 + 0.00 
3 1.30 + 0.20 
4 1.60 + 0.04 
5 2.40 + 0.05 
6 3.10 + 0.00 
7 5.04 + 0.10 
8 6.20 + 0.15 
 
 
Figure 9. The SPR time series for a surface containing 7 monolayers composed of alternating Hep/Tmc layers, the initial and 
final layers both being Tmc. The arrows indicate the start of the adsorption and rinse steps respectively. After the 7th layer the 
surface is exposed to negatively charged Hep/Chi nanoparticles. Once the nanoparticles are adsorbed the surface is finally 











Figure 10. The SPR results for a heparin terminated surface (a) exposed to fibrinogen and a Tmc terminated surface (b) exposed 
to fibrinogen. The thickness for a heparin terminated surface (c) exposed to fibrinogen and a Tmc terminated surface (d) exposed 
to fibrinogen using Fresnel caclculations. 
3.3 SURFACE MORPHOLOGY 
The surfaces prepared in the SPR flow cell was imaged using AFM as well as SEM. 
AFM and SEM were used to study the features of the surface after the deposition of the 
nanoparticles. The AFM and SEM images are shown in figure 11. Based on these images we can 
see that the nanoparticles were deposited onto the surface of the Hep/Tmc PEMs but are hardly 
deposited on the Hep/Chi PEMs. Several attempts were made to adsorb Hep/Chi PCNs onto 
Hep/Chi PEMs but were not successful. For example, the layers onto which the nanoparticles 
adsorb was increased but this did not solve the problem. Using nanoparticles with a higher 
negative charge was also attempted but was unsuccessful. The nanoparticles not adsorbing on to 
the Hep/Chi PEMs might be because the terminating chitosan layer does not interact as strongly 
with the PCNs as does the Tmc layer on the Hep/Tmc PEMs. From the SEM images we can see 
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how much better the adsorption of the PCNs is on the Hep/Tmc PEMs compared to the Hep/Chi 
PEMs. Since Tmc is more postively charged than Chi we see that the nanoparticles are somewhat 
collapsed on the surface and there is uniform coverage on the surface. These results prompted us 
to abandon Hep/Chi PEMs and focus on only using Hep/Tmc PEMs for all further studies. 
The pair of AFM and SEM images are of the same surface for the Hep/Tmc PEMs and 
Hep/Chi PEMS. The AFM images were taken prior to the SEM images to avoid imaging the 
surface with an extra layer of gold which is required for the SEM image. Images of nanoparticles 
adsorbed onto the surface of Hep/Tmc PEMs are in agreement with one another, they both show 
that the nanoparticles are on the order of 500 nm. The AFM also measures the height of the 
surface, not shown in figure 11, but from the AFM it was determined that the height of the 
nanoparticles was on the order of 30 nm. It should be noted that these images show the 
morphology of the surface under a dry state. This is not exactly what we were after; we want to 
see if they swell after being immersed in liquid buffer such as PBS. From image (a) we can see 
that the nanoparticles seem to be collapsed on the surface, this can be a result of the strong 
interaction between negatively charged nanoparticles and the positively charged Tmc monolayer. 
Both images also confirm that there is a uniform coverage of the surface. This is crucial if this 
technique is to have any application in blood-contacting surfaces. If underlying surface is 
exposed then there is a possibility of platelet adhesion which can further lead to clotting. Since 
the surface is uniformly covered we expect that once the surface is immersed in buffer that the 






Figure 11. SEM (a) and AFM (b) images of the negatively charged Hep/Chi nanoparticles on Hep/Tmc based PEMs. Both of 
these images confirm the deposition of nanoparticles on to the surface. SEM (c) and AFM (d) images of negatively charged 
Hep/Chi nanoparticles on Hep/Chi based PEMs. When Hep/Chi PEMs were used we observed that there was no adsorption of 
nanoparticles on Hep/Chi based PEMs. Unlike SPR where the size of the nanoparticles is difficult to determine, with SEM and 
AFM the size of the nanoparticles is approximately 500 nm.  The top set of images are of the same surface as are the bottom, 
AFM was done before SEM. 
3.4 SURFACE CHEMISTRY 
PM-IRRAS was also performed before the surfaces were prepared for SEM. Three 
different surfaces that were exposed to fibrinogen were analyzed: Hep-terminated, Tmc-
terminated, and PCN-terminated. Surfaces without protein were also analyzed for comparison. 
The goal was to see if the coated surfaces were able to resist fibrinogen adhesion. The PM-
IRRAS spectra for the six surfaces is presented in figure 12. A complete analysis of peak 
assignment for Hep/Tmc PEMs is covered in previous work done in the lab [36]. From these 
spectra we can definitely confirm that these are Hep/Tmc PEMs. There is a characteristic peak at 
1252 cm−1 due to the asymmetric stretching of sulfate groups on the Hep. It should also be noted 
that this peak also seems to increase in the PCN layer due to the increase in sulfate groups 
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present in the Hep/Chi nanoparticles. From the Tmc-terminated layer we can see that there are 
two strong peaks at 1620 cm−1 and 1680 cm−1. These peaks are result of carbonyl stretching in 
the protein backbone and other modes of stretching in the protein. These two peaks are very 
distinct in the Tmc layer whereas on the Hep and PCN layers there is a broad peak which seems 
to have smaller peaks. This peak present from 1700 – 1600 cm−1 was also present in previous 
spectra taken in our lab. This broad absorption peak is characteristic of asymmetric stretch of the 
amide carbonyl groups.  
Since we collected the spectra for both types of surfaces, with and without protein, we 
were able to perform a calculation that allowed us to see if protein had adsorbed on to the 
surface. We performed this simple calculation by normalizing each spectrum with its total area 
from 1000 to 2000 wavenumbers and then taking the difference between the adsorbed surface 
and the protein free surface to obtain the difference. From this difference we can tell weather 
protein adsorbed or not. From figure 12 we can see from the spectra of the Tmc-terminated 
surface that there are lots of changes upon protein adsorption indicating lots of fibrinogen 
adsorbed. The Hep-terminated and PCN-Terminated spectra show that there is very little change 
upon protein adsorption indicating very little change in chemistry. This is also confirmed by the 
difference curves, we can see that both the Hep-terminated and PCN-terminated curves are 
featureless compared to the Tmc-terminated surface. From this we can conclude that Tmc-





Figure 12. The PM-IRRAS spectra for Hep-terminated PEM with (blue) and without (red) fibrinogen, Tmc-terminated PEM with 
(blue) and without (red) fibrinogen, and PCN-terminated with (blue) and without (red) fibrinogen. The difference between the 
spectra was taken to see if protein had adsorbed to surfaces that were exposed to protein. Based on the difference we can see that 
Hep-terminated and PCN-terminated have no protein adsorption since the spectra are same before and after protein adsorption. 















3.5 FORMATION OF PEMS AND PCN-COATED SURFACE USING QCM 
 The surfaces were also prepared using QCM, with this technique we can monitor the 
deposition of PEMs and PCN by monitoring shift in frequencies. We can then determine the 
thickness, viscosity, and sheer modulus of the surface under liquid conditions, something that we 
were not able to do using SPR. As mentioned earlier, Kelvin-Voigt model is used to solve for 
thickness, viscosity, and sheer modulus. For this model to give an accurate description of the 
surface there are few key assumptions made: the film must be laterally homogenous and evenly 
distributed, the bulk fluid is Newtonian, the adsorbed layer couples perfectly to the sensor (no 
slip), and the film is soft/viscoelastic. A surface containing Hep/Tmc PEMs and Hep/Chi PCN 
was prepared, the overtones n = 3, 5, 7, 9, 11, 13 were measured as a function of time. It should 
be noted that QCM was only used to analyze PCN adsorption onto Hep/Tmc PEMs and not 
Hep/Chi PEMs. As mentioned in section 3.3, once we observed that Hep/Chi based PEMs were 
poor at adsorbing the PCNs we decided to only use Hep/Tmc PEMs for further studies. The 
adsorption of the PEMs and PCNs process using the QCM is shown in figure 13. Just based on 
the frequency data we can tell a little bit about the nature of the surface. The first seven layers 
seem to be stiff since the frequency shifts are all close to one another. After the adsorption of the 
PCN layer we observer that the overtones segregate indicating that we might have a softer layer. 
The shift in frequency is an indication of mass adsorption. We observe that once fibrinogen is 
added (after 250 minutes) and a rinse step is done, the frequency shift goes above the previous 
step. This is an indicative of loss of mass. This might be due to fibrinogen binding to the 
nanoparticles and displacing water. It should also be noted that dissipation data was also 
measured but was excluded when using the model to calculate sheer modulus, viscosity, and 
thickness. This was done because the dissipation data contained a lot of noise preventing 
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acceptable fit of the model when included. Therefore only n = 5, 7, 9, 13 overtones were used to 
calculate the sheer modulus, viscosity and thickness of the layers.  
 
	  
Figure 13. The adsorption of PEMs and PCNs using QCM. This shows the adsorption of 7 multilayers followed by the adsorption 
of PCNs and then finally fibrinogen. The arrows indicate the start of adsorption and rinse steps respectively. As can be seen from 
the frequency, the layers seem to be stiff up until the 7 layer. Once the PCN layer is added we see a split in the frequency which 
is characteristic of more viscous layers. 
 Using the Q-tools software we were able to determine the the thickness, viscosity, and 
sheer modulus of our surfaces for the various cases mentioned. The results for these various 
cases is presented table 3. From Q-tools using the Kelvin-Voight model we determine that the 
underlying PEM layer has a thickness of 19.0 + 0.08 nm thickness. Once the properties of the 
underlying PEM were determined it was lumped into one layer for futher calculations, meaning 
that the properties of the seventh layer defines the entire PEM layer. Q-tools has the ability to 
calculate the properites of two-layer systems with the quartz and bulk layer being already taken 
into account as the third and fourth layers. This gave us the flexibility to try different 







assumed that the PEM layer and PCN layer was one layer. By making this assumption we are 
treating both of these layers as the same, meaning that they are both viscous or very stiff. This 
might not be the case in reality. By making this assumption we see that the thickness of this layer 
is 31.5 + 0.6 nm, the sheer modulus is 0.03 + 0.02 MPa, and the viscoisty is 2.2 + 0.1 cP. The 
thickness of the entire layer seems to be quite small, this might be because we are assuiming that 
the PEM layer and the PCN both have the same mechanical properties, when in reality they 
might have completly different properties. It should be noted that when calculating these 
properties we assumed that the density of the PEM layer was 1400 kg/m3. This was done because 
we expect the density of the polysaccharide solutions to be between that of water (1000 kg/m3) 
and a very concentrated solution of polysaccharides (1500 kg/m3). When the density was varied 
from 1000 kg/m3 to 1500 kg/m3, it was observed that a density of 1400 kg/m3 gave the best fit.  
 Even though we modeled various cases, only a few of them make physical sense. For 
example, from case 1b we see that the thickness of the nanoparticles layer is 70.0 + 13 nm. This 
result is very simlar to the result we obtained from AFM. Using the AFM we were able to 
detrmine that the height of the nonoparticles on the surface was approximately 30 nm in the dry 
state. Therefore the thickness of 70.0 + 13 nm physically makes sense since we expect the 
nanoparticles to swell. For some of the other cases, the reason that the QCM might not be giving 
us better results is because in our original model we assumed that the nanoparticles are 
uniformally distrubted over the surface and  they are coupled to the underlying surface. We 
belive that the nanoparticles might not be completley coupled to the surface. The vibrating 
crystal might be preventing the PCNs from coupling to the surface, thus giving an inaccurate 
discription of the surface properties. But based on the SEM and AFM images we are confident 
that we have a surface that behaves like a brush when under fluid. Again, even though we were 
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able to use the model to calulate the properties of case 1a and case 1c we do not belivieve they 
provide any valuable inforamtion, they were done for the sake of completeness. The PEM and 
PCN layers have completely different properties therefore combining them into one layer does 
not give an accurate discription of that layer. We expect the PCNs to be highly hydrated 
therefore their viscosity should be close to that of water. But what we observe from the QCM is 
that the viscoisty of case 1b is lower than that of water. Again this might all go back to the 
nanoparticles not being completley coupled to the surface. Therefore, we are not getting an 
accurate discription of the surface properties.  
 One thing we do observe is that we are definetly getting PEM formation and PCN 
adsroption. We can compare the thickness obtained from QCM and the peak shift from the SPR 
in figure 14. From this plot we see that after the adsoption of PCNs at layer 7 we see that in the 
SPR plot that there is a slight peak postion where as in the QCM data we see a huge increase in 
thickness. This shows that we definetly have PCNs that are on the surface but we just werent 
able to accurately obtain that thickness using SPR. This is because SPR detrmines the thickness 
based on changes in refractive indicies. If the nanoparticles are highly hydrated then they will 
have a refractive index colose to that of water. If the refractive index of the rinse solution and the 
PCN solutions are very similar then we expect the peak not to shift by that much. This results in 
us not being to able to measure the thickness of this particular layer. That is why we resort to 
using the QCM.  
 Even though case 1a and 1c are not very useful, case 1d might tell us somewhat of the 
inteaction between the nanoparticles and the fibrinogen. From case 1b we see that the thickness 
of the nanoparticles before fibrinogen adsorption is 70.0 + 13 nm. Once we expose the surface to 
fibrinogen and treat the nanoparticle and fibrinogen layer as one layer we see from case 1d that 
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this layer has a thickness of 26.0 + 2.0 nm. This might indicate that the nanoparticles collapse 
once exposed to fibrinogen as a result of fibrinogen displacing the water. 
 Though the QCM results are postive we did not expect to get some of the values that we 
did. Most of the results obtainted for the thickness make physical sense but the results for the 
sheer modulus and viscosity are not what we were expecting. To use the Kelvin-Voigt model, it 
was assumed that the film is completely coupled to the surface. In reality this might not be true, 
therefore we are not getting a true representation of the sheer moduls and viscosity of the 
surface.  If the nanoparticles are hydrated we were expecting the surface to have a viscosity close 
to that of water but instead we get values that are much lower in comparison. Same for the sheer 
modulus, we were expecting much larger values but instead the values are very small. This all 
goes back to the nanoparticles possibly not being coupled to the surface. If we can somehow 
create conditions in which the nanoparticles are able to couple with the underlying surface we 
might get results that are significantly better. Also, we ignored the dissipation data when 
calulating all the quantities in table 3 because it was  noisy and prevented an acceptable fit of the 
model. Again the dissipation data might have been noisy because of the PCNs not being 











Table 3. The thickness, viscosity, and sheer modulus for the cases presented in figure 8. These values were obtained from Q-tools 
using the Kelvin-Voigt model. The thickness, viscosity, and sheer modulus of each monolayer in the PEM was also determined. 
 h1 (nm) µ1 (MPa) η1 (cP) h2 (nm) µ 2 (MPa) η 2 (cP) 
Layer PEM Layer 
3 4.60 + 0.05 0.26 + 0.01 2.7E-7 + 2.0E-8    
4 7.4 + 0.1 1.1 + 0.3 1.4 + 0.8    
5 11.7 + 0.1 1.5 + 0.1 4.0 + 1.0    
6 12.5 + 0.1 1.8 + 0.4 2.0 + 1.0    
7 19.0 + 0.1 1.9 + 0.1 5.0 + 0.6    
Naoparticle and Protein layer 
Case 1a    31.5 + 0.6 0.03 + 0.02 2.2 + 0.1 
Case 1b 19.0 + 0.1 1.9 + 0.1 5.0 + 0.6 70.0 + 13 0.01 + 0.0015 0.75 + 0.02 
Case 1c 31.5 + 0.6 0.03 + 0.02 2.2 + 0.1 1.70 + 0.05 0.0100 + 0.0002 0.16 + 0.003 





Figure 14. The adsorption of the PEMs using SPR (top) and the thickness of the PEMs using QCM (bottom). The top plot shows 
the average shift in peak position and the bottom shows the average thickness. From this plots we can see that there is PCN 
deposition on the surface (layer number 8). In SPR there is a slight shift in peak position that somewhat confirms there is PCN 

















 In this work, we developed and characterized a surface based on polysaccharide based 
polyelectrolyte multilayers (PEM) and polyelectrolyte complex nanoparticles (PCN). By 
adsorbing PCNs onto the surface we have a surface that has brush-like features that are similar to 
those found on the luminal surface of blood vessels. From atomic force microscopy (AFM) and 
scanning electron microscope (SEM) we analyze the nanoscale features of the surface. From 
these techniques we see that the surface has a uniform coverage of PCNs that are approximately 
400 nm in diameter and 20-30 nm in height in dry conditions. Using quartz crystal microbalance 
(QCM) and surface plasmon resonance (SPR) we were able to study the properties of the surface 
when immersed in liquid. From these studies we concluded that under fluid conditions the PCNs 
do in fact swell up like we had originally hypothesized. From our preliminary work regarding 
fibrinogen adhesion we were not able to draw direct conclusion on the ability of the surface to 
resist protein adhesion. Combining all the results from all the techniques, we are confident that 
we have a surface that has a dense brush-like structure when immersed in liquid. These surfaces 
should be further evaluated to determine their blood compatibility to determine their suitability 










[1] Zhu DM, Fang JJ, Wu B, Du XB. Viscoelastic response and profile of adsorbed molecules 
probed by quartz crystal microbalance. Physical Review E. 2008;77:7. 
[2] Ratner BD. The catastrophe revisited: Blood compatibility in the 21st century. Biomaterials. 
2007;28:5144-7. 
[3] Lamba NMK, Baumgartner JN, Cooper SL. The influence of thrombus components in 
mediating bacterial adhesion to biomaterials. Journal of Biomaterials Science-Polymer Edition. 
2000;11:1227-37. 
[4] Tassiopoulos AK, Greisler HP. Angiogenic mechanisms of endothelialization of 
cardiovascular implants: a review of recent investigative strategies. Journal of Biomaterials 
Science-Polymer Edition. 2000;11:1275-84. 
[5] Yu K, Lai BFL, Kizhakkedathu JN. Carbohydrate Structure Dependent Hemocompatibility of 
Biomimetic Functional Polymer Brushes on Surfaces. Advanced Healthcare Materials. 
2012;1:199-213. 
[6] Reitsma S, Slaaf DW, Vink H, van Zandvoort M, Egbrink M. The endothelial glycocalyx: 
composition, functions, and visualization. Pflugers Archiv-European Journal of Physiology. 
2007;454:345-59. 
[7] Brash JL. Exploiting the current paradigm of blood-material interactions for the rational 
design of blood-compatible materials. Journal of Biomaterials Science-Polymer Edition. 
2000;11:1135-46. 
[8] Li S, Henry JJD. Nonthrombogenic Approaches to Cardiovascular Bioengineering. In: 
Yarmush ML, Duncan JS, Gray ML, editors. Annual Review of Biomedical Engineering, Vol 
13. Palo Alto: Annual Reviews; 2011. p. 451-75. 
[9] Jung F, Braune S, Lendlein A. Haemocompatibility testing of biomaterials using human 
platelets. Clinical Hemorheology and Microcirculation. 2013;53:97-115. 
[10] Sen Gupta A, Wang S, Link E, Anderson EH, Hofmann C, Lewandowski J, et al. 
Glycocalyx-mimetic dextran-modified poly(vinyl amine) surfactant coating reduces platelet 
adhesion on medical-grade polycarbonate surface. Biomaterials. 2006;27:3084-95. 
[11] Werner C, Maitz MF, Sperling C. Current strategies towards hemocompatible coatings. 
Journal of Materials Chemistry. 2007;17:3376-84. 
[12] Nieuwdorp M, Meuwese MC, Vink H, Hoekstra JBL, Kastelein JJP, Stroes ESG. The 
endothelial glycocalyx: a potential barrier between health and vascular disease. Current Opinion 
in Lipidology. 2005;16:507-11. 
[13] Secomb TW, Hsu R, Pries AR. Effect of the endothelial surface layer on transmission of 
fluid shear stress to endothelial cells. Biorheology. 2001;38:143-50. 
[14] Barrientos AG, de la Fuente JM, Rojas TC, Fernandez A, Penades S. Gold 
glyconanoparticles: Synthetic polyvalent ligands mimicking glycocalyx-like surfaces as tools for 
glycobiological studies. Chemistry-a European Journal. 2003;9:1909-21. 
[15] Bosker WTE, Patzsch K, Stuart MAC, Norde W. Sweet brushes and dirty proteins. Soft 
Matter. 2007;3:754-62. 
[16] Parnell AJ, Martin SJ, Jones RAL, Vasilev C, Crook CJ, Ryan AJ. Direct visualization of 
the real time swelling and collapse of a poly(methacrylic acid) brush using atomic force 
microscopy. Soft Matter. 2009;5:296-9. 
48 
	  
[17] Sui XF, Zapotoczny S, Benetti EM, Schon P, Vancso GJ. Characterization and molecular 
engineering of surface-grafted polymer brushes across the length scales by atomic force 
microscopy. Journal of Materials Chemistry. 2010;20:4981-93. 
[18] Vladkova TG. Surface Engineered Polymeric Biomaterials with Improved Biocontact 
Properties. International Journal of Polymer Science. 2010. 
[19] Pries AR, Secomb TW, Gaehtgens P. The endothelial surface layer. Pflugers Archiv-
European Journal of Physiology. 2000;440:653-66. 
[20] Boddohi S, Kipper MJ. Engineering Nanoassemblies of Polysaccharides. Advanced 
Materials. 2010;22:2998-3016. 
[21] Biomaterials science an introduction to materials in medicine. San Diego: Academic Press; 
1996. 
[22] Ly M, Laremore TN, Linhardt RJ. Proteoglycomics: Recent Progress and Future 
Challenges. Omics-a Journal of Integrative Biology. 2010;14:389-99. 
[23] Malavaki CJ, Theocharis AD, Lamari FN, Kanakis I, Tsegenidis T, Tzanakakis GN, et al. 
Heparan sulfate: biological significance, tools for biochemical analysis and structural 
characterization. Biomedical Chromatography. 2011;25:11-20. 
[24] Olson ST, Bjork I. REGULATION OF THROMBIN ACTIVITY BY ANTITHROMBIN 
AND HEPARIN. Seminars in Thrombosis and Hemostasis. 1994;20:373-409. 
[25] Wu KK, Thiagarajan P. Role of endothelium in thrombosis and hemostasis. Annual Review 
of Medicine. 1996;47:315-31. 
[26] Bedsted T, Swanson R, Chuang YJ, Bock PE, Bjork I, Olson ST. Heparin and calcium ions 
dramatically enhance antithrombin reactivity with factor IXa by generating new interaction 
exosites. Biochemistry. 2003;42:8143-52. 
[27] Dalainas I, Avgerinos ED, Liapis CD. Heparin-induced thrombocytopenia: what a vascular 
surgeon needs to know. Journal of Cardiovascular Surgery. 2011;52:81-8. 
[28] Lagergre.H, Olsson P, Swedenbo.J. INHIBITED PLATELET ADHESION - NON-
THROMBOGENIC CHARACTERISTIC OF A HEPARIN-COATED SURFACE. Surgery. 
1974;75:643-50. 
[29] Yoon JH, Jang IK. Heparin-Induced Thrombocytopenia in Cardiovascular Patients 
Pathophysiology, Diagnosis, and Treatment. Cardiology in Review. 2011;19:143-53. 
[30] Olsson P, Lagergren H, Larsson R, Radegran K. PREVENTION OF PLATELET-
ADHESION AND AGGREGATION BY A GLUTARDIALDEHYDE-STABILIZED 
HEPARIN SURFACE. Thrombosis and Haemostasis. 1977;37:274-82. 
[31] Jaax ME, Greinacher A. Management of heparin-induced thrombocytopenia. Expert 
Opinion on Pharmacotherapy. 2012;13:987-1006. 
[32] Otis SA, Zehnder JL. Heparin-induced thrombocytopenia: Current status and diagnostic 
challenges. American Journal of Hematology. 2010;85:700-6. 
[33] Chen JL, Li QL, Chen JY, Chen C, Huang N. Improving blood-compatibility of titanium by 
coating collagen-heparin multilayers. Applied Surface Science. 2009;255:6894-900. 
[34] Boddohi S, Almodovar J, Zhang H, Johnson PA, Kipper MJ. Layer-by-layer assembly of 
polysaccharide-based nanostructured surfaces containing polyelectrolyte complex nanoparticles. 
Colloids and Surfaces B-Biointerfaces. 2010;77:60-8. 
[35] Boddohi S, Moore N, Johnson PA, Kipper MJ. Polysaccharide-Based Polyelectrolyte 




[36] Almodovar J, Place LW, Gogolski J, Erickson K, Kipper MJ. Layer-by-Layer Assembly of 
Polysaccharide-Based Polyelectrolyte Multilayers: A Spectroscopic Study of Hydrophilicity, 
Composition, and Ion Pairing. Biomacromolecules. 2011;12:2755-65. 
[37] Frutos AG, Weibel SC, Corn RM. Near-infrared surface plasmon resonance measurements 
of ultrathin films. 2. Fourier transform SPR spectroscopy. Analytical Chemistry. 1999;71:3935-
40. 
[38] Boddohi S, Killingsworth CE, Kipper MJ. Polyelectrolyte multilayer assembly as a function 
of pH and ionic strength using the polysaccharides chitosan and heparin. Biomacromolecules. 
2008;9:2021-8. 
[39] Liu SX, Kim JT. Application of Kevin-Voigt Model in Quantifying Whey Protein 
Adsorption on Polyethersulfone Using QCM-D. Jala. 2009;14:213-20. 
[40] Alves NM, Picart C, Mano JF. Self Assembling and Crosslinking of Polyelectrolyte 
Multilayer Films of Chitosan and Alginate Studied by QCM and IR Spectroscopy. 
Macromolecular Bioscience. 2009;9:776-85. 
[41] Voinova MV, Rodahl M, Jonson M, Kasemo B. Viscoelastic acoustic response of layered 
polymer films at fluid-solid interfaces: Continuum mechanics approach. Physica Scripta. 
1999;59:391-6. 
[42] Hansen WN. ELECTRIC FIELDS PRODUCED BY PROPAGATION OF PLANE 
COHERENT ELECTROMAGNETIC RADIATION IN A STRATIFIED MEDIUM. Journal of 
the Optical Society of America. 1968;58:380-&. 
	  
 
